Corrigendum to "Discovery of benzofuran propanoic acid GPR120 agonists: From uHTS hit to mechanism-based pharmacodynamic effects" [Bioorg. Med. Chem. Lett. 26 (2016) 5724-5728].

Autor: Lombardo M; Merck & Co., Inc., Kenilworth, NJ, USA. Electronic address: matthew_lombardo@merck.com., Bender K; Merck & Co., Inc., Kenilworth, NJ, USA., London C; Merck & Co., Inc., Kenilworth, NJ, USA., Plotkin MA; Merck & Co., Inc., Kenilworth, NJ, USA., Kirkland M; Merck & Co., Inc., Kenilworth, NJ, USA., Mane J; Merck & Co., Inc., Kenilworth, NJ, USA., Pachanski M; Merck & Co., Inc., Kenilworth, NJ, USA., Geissler W; Merck & Co., Inc., Kenilworth, NJ, USA., Cummings J; Merck & Co., Inc., Kenilworth, NJ, USA., Habulihaz B; Merck & Co., Inc., Kenilworth, NJ, USA., Akiyama TE; Merck & Co., Inc., Kenilworth, NJ, USA., Di Salvo J; Merck & Co., Inc., Kenilworth, NJ, USA., Madeira M; Merck & Co., Inc., Kenilworth, NJ, USA., Pols J; Merck & Co., Inc., Kenilworth, NJ, USA., Powles MA; Merck & Co., Inc., Kenilworth, NJ, USA., Finley MF; Merck & Co., Inc., Kenilworth, NJ, USA., Johnson E; Merck & Co., Inc., Kenilworth, NJ, USA., Roussel T; Merck & Co., Inc., Kenilworth, NJ, USA., Uebele VN; Merck & Co., Inc., Kenilworth, NJ, USA., Crespo A; Merck & Co., Inc., Kenilworth, NJ, USA., Leung D; Merck & Co., Inc., Kenilworth, NJ, USA., Alleyne C; Merck & Co., Inc., Kenilworth, NJ, USA., Trusca D; Merck & Co., Inc., Kenilworth, NJ, USA., Lei Y; Merck & Co., Inc., Kenilworth, NJ, USA., Howard AD; Merck & Co., Inc., Kenilworth, NJ, USA., Ujjainwalla F; Merck & Co., Inc., Kenilworth, NJ, USA., Tata JR; Merck & Co., Inc., Kenilworth, NJ, USA., Sinz CJ; Merck & Co., Inc., Kenilworth, NJ, USA.
Jazyk: angličtina
Zdroj: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2017 Mar 01; Vol. 27 (5), pp. 1333. Date of Electronic Publication: 2017 Feb 04.
DOI: 10.1016/j.bmcl.2017.01.082
Databáze: MEDLINE
Externí odkaz: